Dear Jolene,

I am writing on behalf of the Minister David Sergeenko, as I was informed you are the person who is responsible for arranging the teleconference call between the Minister and Mr. Robertson.

The possible date and time for the conference call would be: June 14^th or 15^th ,2017 at 17:00- 20:00 (Tbilisi time).

Please let us know which possible date and time suits you.

Next week I will have limited access to my Email, so I have cc-ed my colleague Mariana Mkurnali, she can assist you with the details.

Should you have any questions please do not hesitate to contact me.

Best regards,

Dear David,

 

I hope all well with you and all is going well in Georgia.

I really want to try to visit during the summer however in the meantime I was wondering if we could arrange a quick teleconference to discuss some ideas with you.

 

Please let me know when would be a good time for us to call. Jolene my admin can help to set this up.

 

Thank you and best wishes

 

Graeme

 

Graeme.A Robertson

Senior Director,  Africa & CIS

Access Operations & Emerging Markets 

 

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd • Registered as a limited company in England and Wales • Registered number 05510315

Registered office: South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone: +44(0)208 587 2228 • Mobile: +44(0)7789 268 043 • Fax: +44(0)208 744 6773

 

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England